Supplementary material for "Oral semaglutide and CV benefits in the SOUL trial: how do baseline or changes in HbA1c or BMI affect clinical outcomes?"
Year: 2026
Type: supplementary-materials
Abstract: Supplementary material for the "Oral semaglutide and CV benefits in the SOUL trial: how do baseline or changes in HbA1c or BMI affect clinical outcomes?" manuscript
Source: Figshare
Authors: Silvio E. Inzucchi, Rohana Abdul Ghani, John Deanfield, Scott S. Emerson, Mads D. M. Engelmann, G. Kees Hovingh, Ole K Jeppesen, Monika Kellerer, Kabirdev Mandavya, Johannes F. Mann, Nikolaus Marx, Chantal Mathieu, Darren K. McGuire, Viswanathan Mohan, Sharon L. Mulvagh, Rodica Pop‑Busui, Neil R. Poulter, Neda Rasouli, Maria Sejersten Ripa, Gabriela Roman, Róbinson Sánchez García, Michael Shechter, John B. Buse
Institution: University College London
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7170136545